Zimmer Biomet Holdings Inc. closed its offering of €500 million of 1.414% senior unsecured notes due 2022 and €500 million of 2.425% senior unsecured notes due 2026.
The offering of the notes closed Dec. 13.
The company used the net proceeds to pay for the senior notes it purchased in its cash tender offers.
In the tender offers, the company accepted for purchase the aggregate principal amount of each series of notes validly tendered and not validly withdrawn on or before 5 p.m. ET Dec. 5. Settlement of the notes accepted for purchase took place Dec. 13, and notes purchased in the offers were retired and canceled.
Zimmer has not accepted, and will not accept, for purchase any tenders of notes after Dec. 5 as the aggregate purchase price of the notes tendered before the deadline exceeds the maximum tender amount of $1.25 billion.